and the results indicate that ozone therapy could increase oxygenation in the most hypoxic tumors. This suggests the potential use of this therapy as adjuvant in chemo-radiotherapy schedules.
adjuvant
(of therapy) applied after initial treatment for cancer, especially to suppress secondary tumour formation.
With the use of EBO2 after initial cancer treatment,EBO2 will supply Oxygen which will suppress any secondary tumour formation in the cells.
Going to be a game changer for medicine. And now in particular after the recent Nobel prize this October about the importance of Oxygen availability to fight cancer and many other illnesses thus the importance of the ozone therapy in this process
Ozone therapy is about to go wild with the finds from the Nobel prize.
There seems to be clear evidence that this works BUT... I like to look at leader in the field of oxygenation. I think the parallel your draw to the Nobel Prize is interesting but there are way more journal articles that talk about hypoxia. Ever hear of BIXT?
See having a needle in your arm for therapy just isnt my type of fun and a lot of people are needle phobic so if you can get more oxygen for longer using a drug like BXT-25 people are going to choose convenience. So they dont get the elimination of toxins mechanically it wont matter if their organs are operating at peak performance because they have a great supply of oxygen.
So your analysis is spot on and I commend you for that but I like to go with best in Breed and have a longer term perspective. BIXT with their development team has a much better chance of getting this approved in cancer. So I share your enthusiasm but cancer is all about Immunotherapy and oxygenation is key during chemotherapy and few people should be using that when immunotherapy is improving so rapidly.
News 
Market Data 
Discover 
